Trem1−/− and Trem1+/+ mice were injected twice with the procarcinogen AOM and subjected to three cycles of DSS administration, followed by an additional latency period to allow for visible tumor growth (Fig. 1a). This evidence concerns the gene TREM1 and infectious otitis media.